Company / EPS (Diluted)
IDEAYA Biosciences, Inc. EPS (Diluted) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.96
FY2025
5-year range
-$3.36 / -$1.40
FY2021-FY2025
Trend
-38.0%
vs FY2024
Sector context
#119 of 204
Health Care
What the data says
At $-1.96, IDEAYA Biosciences, Inc.'s eps (diluted) ranks #119 of 204 in the Health Care sector. EPS (Diluted) has declined for 3 consecutive years, from $-1.40 in FY2022 to $-1.96 in FY2025.
Based on SEC 10-K filings.
-1.96 in FY2025.
Declined from $-1.41 to $-1.96 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#119 of 204 in Health CareTop 58% of 204This company -$1.96 Sector average -$0.98
▼
-100.1% below sector average
Key checks
Key Insights
- IDEAYA Biosciences, Inc.'s eps (diluted) has declined for 3 consecutive years.
- In FY2025, eps (diluted) decreased 38.0% year-over-year.
- Ranks #119 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.96 | -38.0% |
| FY2024 | -$1.42 | -0.7% |
| FY2023 | -$1.41 | -0.7% |
| FY2022 | -$1.40 | +58.3% |
| FY2021 | -$3.36 | +90.6% |
| FY2020 | -$35.92 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026